GBCS insider buying
SELECTIS HEALTH, INC.
Every qualifying open-market purchase of GBCS reported to the SEC on Form 4, parsed directly from the filings and linked back to the source on EDGAR. No buying cluster — two or more distinct insiders inside a rolling window — has been detected in GBCS yet; if one forms, it appears here (and hits our alert subscribers in real time).
All notable open-market buys in GBCS
Every open-market Form 4 purchase, newest first. Click an insider to see their full buying record across companies.
| Date | Insider | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| Dec 18, 2025 | Director, 10% Owner | 6,192 | $2.20 | $13.6K | SEC ↗ |
GBCS insider buying — FAQ
- Are insiders buying GBCS stock?
- 1 insider has bought GBCS (SELECTIS HEALTH, INC.) on the open market, most recently on Jan 14, 2026. No cluster buy — two or more distinct insiders within a rolling window — has been detected yet.
- How much GBCS stock have insiders bought?
- Insiders have bought a combined $13.6K of GBCS across 1 open-market purchase, based on SEC Form 4 filings.
- What is an insider cluster buy in GBCS?
- A cluster buy is two or more distinct SELECTIS HEALTH, INC. insiders — officers, directors, or 10% owners — each buying GBCS on the open market within a rolling window. None has been detected in GBCS yet.
- Where does this GBCS insider trading data come from?
- Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.
How we track insider buying in GBCS
We continuously poll SEC EDGAR for new Form 4 filings and parse every open-market purchase (transaction code P). A cluster is recorded when two or more distinct insiders — officers, directors, or 10% owners — each buy GBCS within a rolling window. We track clusters at every company size, from micro-caps to mega-caps. Every figure on this page traces back to an official filing; open any row to jump straight to the source document. What counts as a cluster buy?
This page is informational and reflects public filing data. It is not investment advice or a recommendation regarding GBCS.